'Indirect comparisons' presentation slideshows

Applying Bayesian evidence synthesis in comparative effectiveness research

Applying Bayesian evidence synthesis in comparative effectiveness research. David Ohlssen (Novartis Pharmaceticals Corporation). Overview. Part 1 Bayesian DIA CER sub-team Part 2 Overview of Bayesian evidence synthesis. Part 1 Bayesian DIA CER sub-team. Team Members. Chair: David Ohlssen

581 views • 49 slides

511 views • 41 slides

The potential role of mixed treatment comparisons

The potential role of mixed treatment comparisons. Deborah Caldwell Tony Ades MRC HSRC University of Bristol. Outline of presentation. Indirect comparisons and mixed treatment comparisons (MTC). Potential concerns regarding use of indirect comparisons/ MTC.

551 views • 40 slides

Leslie Citrome, MD, MPH Disclosures

Leslie Citrome, MD, MPH Disclosures. In the past 12 months, consultant: Acadia, Alkermes, Allergan, Impel, Indivior, Intra-Cellular Therapeutics, Janssen, Lundbeck, Merck, Neurocrine, Noven, Osmotica, Otsuka, Pfizer, Shire, Sunovion, Takeda, Teva, Vanda

286 views • 28 slides

Plan

Plan. Principles of conventional systematic reviews and meta-analyses Indirect comparisons Network meta-analysis (mixed treatment comparisons meta-analysis). The right question. All cancer therapy for all cancers all antiplatelet agents for all atheroembolic events (heart, head, leg)

391 views • 25 slides

Multiple intervention reviews

Multiple intervention reviews. Reflections from CoEds discussions this week . Portfolio management. initiated and managed by CRGs splitting lumped reviews at update stage OoR and MTM not always necessary/appropriate

287 views • 9 slides

Mealing S et al. Proc ASH 2010;Abstract 3436.

Comparative Efficacy of First-Line Treatment of Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis. Mealing S et al. Proc ASH 2010;Abstract 3436. Objectives.

193 views • 9 slides